Biotech Stock Roundup: KYMR, IDYA, QURE Soar on Study Data, HLVX Tanks on Study Failure
Yahoo Finance · 4 hours ago
Open | 51.43 |
High | 51.54 |
Low | 51.00 |
Mkt Cap | 127.66B |
P/E (TTM) | 26.16 |
Div & Yield | 2.04 & 3.99% |
Prev. Close | 51.03 |
52 Wk. Low | 42.63 |
52 Wk. High | 55.72 |
Related stocks
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 11.12B | 2.30% ▲ |
Net Income | 1.13B | 43.20% ▼ |
Diluted EPS | 0.97 | 43.20% ▼ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $0.86 | - |
Q1 2024 | $0.94 | $0.97 |
Q4 2023 | $0.91 | $0.89 |
S&P 500^GSPC | 5,589.15-44.76 (-0.79%) |
Dow 30^DJI | 39,737.57+16.21 (+0.04%) |
Nasdaq^IXIC | 18,348.93-298.52 (-1.60%) |
7.09+30.96% | |
850.82-3.79% | |
NASDAQ Composite^IXIC | 18,348.93-1.60% |